Repair of critical size defects in the rat cranium using ceramic-reinforced PLA scaffolds obtained by supercritical gas foaming

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 1, 2007, Pages 41-51

  Montjovent, Marc Olivier ^a   Mathieu, Laurence ^b   Schmoekel, Hugo ^a,c   Mark, Silke ^d   Bourban, Pierre Etienne ^b   Zambelli, Pierre Yves ^e   Laurent Applegate, Lee Ann ^f   Pioletti, Dominique P ^a  

^a EPFL   (Switzerland)

^b LABORATOIRE DE TECHNOLOGIE DES COMPOSITES ET POLYMÈRES LTC   (Switzerland)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e Hopital Orthopedique de la Suisse Romande   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Biocompatibility; Biomaterials; Bone tissue engineering; Polylactic acid; Scaffold

Indexed keywords

BONE; GRAFTS; HISTOLOGY; TISSUE ENGINEERING;

BONE TISSUE ENGINEERING; OSTEOCONDUCTIVITY; POLYLACTIC ACID; SUPERCRITICAL GAS FOAMING;

BIOMATERIALS;

BIOMATERIAL; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BODY WEIGHT; BONE CONDUCTION; BONE REGENERATION; CONTROLLED STUDY; CRANIOTOMY; FEMALE; HISTOPATHOLOGY; LEUKOCYTE COUNT; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD CELL COUNT; BODY WEIGHT; BONE SUBSTITUTES; CERAMICS; CYTOKINES; GASES; IMPLANTS, EXPERIMENTAL; LACTIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SKULL; TISSUE ENGINEERING; WOUND HEALING;

EID: 34548760256     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31208     Document Type: Article

References (51)

1. Montjovent MO, Mathieu LM, Hinz B, Applegate LL, Bourban PE, Zambelli PY, Månson JAE, Pioletti DP. Biocompatibility of bioresorbable PLA composite scaffolds obtained by supercritical gas foaming with human fetal bone cells. Tissue Eng 2005;11:1640-1649.
2. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg. 1990;1(1):60-68.
3. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986:299-308.
4. Prolo DJ, Pedrotti PW, Burres KP, Oklund S. Superior osteogenesis in transplanted allogeneic canine skull following chemical sterilization. Clin Orthop Relat Res 1982(168):230-242.
5. Aalami OO, Nacamuli RP, Lenton KA, Cowan CM, Fang TD, Fong KD, Shi YY, Song HM, Sahar DE, Longaker MT. Applications of a mouse model of calvarial healing: Differences in regenerative abilities of juveniles and adults. Plast Reconstr Surg 2004;114:713-720.
6. Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001;83-A:1032-1039.
7. Mulliken JB, Glowacki J. Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg 1980;65:553-560.
8. Turnbull RS, Freeman E. Use of wounds in the parietal bone of the rat for evaluating bone marrow for grafting into periodontal defects. J Periodontal Res 1974;9:39-43.
9. Freeman E, Turnbull RS. The value of osseous coagulum as a graft material. J Periodontal Res 1973;8:229-236.
10. Ray RD, Holloway JA. Bone implants; preliminary report of an experimental study. J Bone Joint Surg Am 1957;39-A:1119-1128.
11. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg 1980;38:176-180.
12. Kramer IR, Killey HC, Wright HC. A histological and radiological comparison of the healing of defects in the rabbit calvarium with and without implanted heterogeneous anorganic bone. Arch Oral Biol 1968;13:1095-1106.
13. Costantino PD, Friedman CD, Jones K, Chow LC, Sisson GA. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg 1992;90:174-185; discussion 186-191.
14. Friedenberg ZB, Lawrence RR. The regeneration of bone in defects of varying size. Surg Gynecol Obstet 1962;114:721-726.
15. Kuemmerle JM, Oberle A, Oechslin C, Bohner M, Frei C, Boecken I, von Rechenberg B. Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty - An experimental study in sheep. J Craniomaxillofac Surg 2005;33:37-44.
16. Viljanen VV, Gao TJ, Lindholm TC, Lindholm TS, Kommonen B. Xenogeneic moose (Alces alces) bone morphogenetic protein (mBMP)-induced repair of critical-size skull defects in sheep. Int J Oral Maxillofac Surg 1996;25:217-222.
17. Lindholm TC, Lindholm TS, Alitalo I, Urist MR. Bovine bone morphogenetic protein (bBMP) induced repair of skull trephine defects in sheep. Clin Orthop Relat Res 1988;227:265-268.
18. Merkx MA, Maltha JC, Freihofer HP, Kuijpers-Jagtman AM. Incorporation of particulated bone implants in the facial skeleton. Biomaterials 1999;20:2029-2035.
19. Ripamonti U. Bone induction in nonhuman primates. An experimental study on the baboon. Clin Orthop Relat Res 1991(269):284-294.
20. Hollinger J, Mark DE, Bach DE, Reddi AH, Seyfer AE. Calvarial bone regeneration using osteogenin. J Oral Maxillofac Surg 1989;47:1182-1186; discussion 1187.
21. An YH, Friedman RJ. Animal models of bone defect repair. In: An YH, Friedman RJ, editors. Animal Models in Othopaedic Research. Boca Raton: CRC Press; 1999. p 241-260.
22. Dahlin C, Alberius P, Linde A. Osteopromotion for cranioplasty. An experimental study in rats using a membrane technique. J Neurosurg 1991;74:487-491.
23. Glowacki J, Altobelli D, Mulliken JB. Fate of mineralized and demineralized osseous implants in cranial defects. Calcif Tissue Int 1981;33:71-76.
24. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982;196:100-109.
25. Laurencin CT, Lu HH. Polymer-ceramic composites for bone-tissue engineering. In: Davies JE, editor. Bone Engineering; 2000. p 462-472.
26. Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials 2003;24:2133-2151.
27. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R. Porous poly(α-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I. Preparation and in vitro characterisation. Biomaterials 2004;25:4185-4194.
28. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R. Preparation and characterization of poly(L-lactic acid) foams. Polymer 1994;35:1068-1077.
29. Thomson RC, Yaszemski MJ, Powers JM, Mikos AG. Hydroxyapatite fiber reinforced poly(α-hydroxy ester) foams for bone regeneration. Biomaterials 1998;19:1935-1943.
30. Nam YS, Park TG. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res 1999;47:8-17.
31. Whang K, Goldstick TK, Healy KE. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials 2000;21:2545-2551.
32. Lo H, Ponticiello MS, Leong KW. Fabrication of controlled release biodegradable foams by phase separation. Tissue Eng 1995;1:15-28.
33. Ma PX, Zhang R, Xiao G, Franceschi R. Engineering new bone tissue in vitro on highly porous poly(α-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 2001;54:284-293.
34. 2. J Control Release 2000;66:177-185.
35. Howdle SM, Watson MS, Whitaker MJ, Popov VK, Davies MC, Mandel FS, Wang JD, Shakesheff KM. Supercritical fluid mixing: Preparation of thermally sensitive polymer composites containing bioactive materials. Chem Commun 2001;1:109-110.
36. Watson MS, Whitaker MJ, Howdle SM, Shakesheff KM. Incorporation of proteins into polymer materials by a novel supercritical fluid processing method. Adv Mater 2002;14:1802-1804.
37. Forman S, Kas J, Fini F, Steinberg M, Ruml T. The effect of different solvents on the ATP/ADP content and growth properties of HeLa cells. J Biochem Mol Toxicol 1999;13:11-15.
38. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996;17:1417-1422.
39. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402.
40. Sheridan MH, Shea LD, Peters MC, Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 2000;64:91-102.
41. Mathieu LM, Montjovent MO, Bourban PE, Pioletti DP, Månson JAE. Bioresorbable composites prepared by supercritical fluid foaming. J Biomed Mater Res A 2005;75:89-97.
42. Bohner M, Doebelin N, Baroud G. Theoretical and experimental approach to test the cohesion of calcium phosphate pastes. Eur Cell Mater 2006;12:26-35.
43. Mathieu L, Bourban P-E, Månson JAE. Processing of homogeneous ceramic/polymer blends for bioresorbable composites. Compos Sci Technol 2006;66:1606-1614.
44. Black J. In vivo implants models. Appendix 2: Rating system for tissue at animal implant sites. Biological Performance of Materials: Fundamentals of Biocompatibility. New York: Marcel Dekker; 1999. p 365.
45. Salthouse TN. Biologic response to sutures. Otolaryngol Head Neck Surg 1980;88:658-664.
46. Gourlay SJ, Rice RM, Hegyeli AF, Wade CW, Dillon JG, Jaffe H, Kulkarni RK. Biocompatibility testing of polymers: In vivo implantation studies. J Biomed Mater Res 1978;12:219-232.
47. Sewell WR, Craver BN. The comparative antigenicity in the guinea pig of sutures from ovine submucosa and bovine serosa. Ann Surg 1955;142:980-985.
48. Woodward SC. Evaluation by light microscopy. In: Recum AFv, editor. Handbook of Biomaterials Evaluation. Philadelphia, PA: Taylor & Francis; 1999. p 599-612.
49. Zislis T, Mark DE, Cerbas EL, Hollinger JO. Scanning electron microscopic study of cell attachment to biodegradable polymer implants. J Oral Implantol 1989;15:160-167.
50. Ibim SM, Uhrich KE, Bronson R, El-Amin SF, Langer RS, Laurencin CT. Poly(anhydride-co-imides): In vivo biocompatibility in a rat model. Biomaterials 1998;19:941-951.
51. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook JA. Peroxisome proliferator activator receptor-γligands, 15-deoxy-δ(12, 14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 2003;171:6827-6837.